Therefore, it is reasonable to suggest that exogenous PAC1 receptor antagonists may have anti-atherogenic potential under a high-fat diet in animal models and humans with highly elevated blood lipid levels, like hypercholesterolemia. This evidence concerns the gene ADCYAP1R1 and familial hypercholesterolemia.